Trademarkia Logo

Canada

C$
DORTIQ
ABANDONED SECTION 36

on 2 Mar 2021

Last Applicant/ Owned by

EYEPOINT PHARMACEUTICALS US INC.

480 Pleasant StreetSuite B300Watertown, MA 02472

US

Serial Number

1898464 filed on 10th May 2018

Correspondent Address

CPST INTELLECTUAL PROPERTY INC.

130 Queens Quay EastEast Tower, Suite 809Toronto,

ONTARIO

CA

M5A0P6

DORTIQ

Trademark usage description

drug delivery agents consisting of polymer compounds that facilitate the delivery of pharmaceuticals for the treatment of diseases and conditions, inc Read More

Classification Information


Class [005]
Drug delivery agents consisting of polymer compounds that facilitate the delivery of pharmaceuticals for the treatment of diseases and conditions, including ocular diseases, namely, uveitis, retinal vein occlusion, macular edema, macular disease, retinal disease, and glaucoma and diseases and conditions in joints, namely, osteoarthritis, bursitis, fibrotic diseases, and infections


Classification kind code

11

Class [010]
Sustained drug delivery systems for pharmaceuticals


Classification kind code

11

Mark Details


Serial Number

1898464

Mark Type

Trademark

Legal History


Action TakenStatus
Submitted for opposition 6
on 2th Mar 2021
Abandoned - Section 36
Submitted for opposition 14
on 8th Dec 2020
Default Notice Sent
Submitted for opposition 12
on 11th Jun 2020
Extension of Time
Submitted for opposition 48
on 13th Mar 2020
Agent Changed
Submitted for opposition 22
on 20th Nov 2019
Search Recorded
Submitted for opposition 20
on 20th Nov 2019
Examiner's First Report
Submitted for opposition 31
on 14th May 2018
Formalized
Submitted for opposition 1
on 11th May 2018
Created
Submitted for opposition 30
on 10th May 2018
Filed